Allgulander C - Search Results

1

WCA recommendations for the long-term treatment of generalized anxiety disorder.

Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety. Allgulander C, et al. CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61. doi: 10.1017/s1092852900006945. CNS Spectr. 2003. PMID: 14767398 Review.

2

Long-term treatment strategies in anxiety disorders.

Allgulander C, Hirschfeld RM, Nutt DJ. Allgulander C, et al. Psychopharmacol Bull. 2002 Summer;36 Suppl 2:79-92. Psychopharmacol Bull. 2002. PMID: 12490824 Review.

3

WCA recommendations for the long-term treatment of panic disorder.

Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP; World Council of Anxiety. Pollack MH, et al. Among authors: allgulander c. CNS Spectr. 2003 Aug;8(8 Suppl 1):17-30. doi: 10.1017/s109285290000691x. CNS Spectr. 2003. PMID: 14767395 Review.

4

WCA recommendations for the long-term treatment of social phobia.

Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP; World Council of Anxiety. Van Ameringen M, et al. Among authors: allgulander c. CNS Spectr. 2003 Aug;8(8 Suppl 1):40-52. doi: 10.1017/s1092852900006933. CNS Spectr. 2003. PMID: 14767397 Review.

5

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.

Allgulander C, Nutt D, Detke M, Erickson J, Spann M, Walker D, Ball S, Russell J. Allgulander C, et al. J Psychopharmacol. 2008 Jun;22(4):417-25. doi: 10.1177/0269881108091588. J Psychopharmacol. 2008. PMID: 18635722

6

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.

Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J. Davidson J, et al. Among authors: allgulander c. Hum Psychopharmacol. 2008 Aug;23(6):519-26. doi: 10.1002/hup.949. Hum Psychopharmacol. 2008. PMID: 18478624

7

An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder.

Baldwin DS, Allgulander C, Bandelow B, Ferre F, Pallanti S. Baldwin DS, et al. Among authors: allgulander c. World J Biol Psychiatry. 2012 Oct;13(7):510-6. doi: 10.3109/15622975.2011.624548. Epub 2011 Nov 7. World J Biol Psychiatry. 2012. PMID: 22059936

8

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.

Lyndon GJ, Prieto R, Wajsbrot DB, Allgulander C, Bandelow B. Lyndon GJ, et al. Among authors: allgulander c. Int Clin Psychopharmacol. 2019 May;34(3):110-118. doi: 10.1097/YIC.0000000000000256. Int Clin Psychopharmacol. 2019. PMID: 30870236 Free PMC article. Clinical Trial.

9

Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.

Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C. Stein DJ, et al. Among authors: allgulander c. J Clin Psychiatry. 2012 Jul;73(7):1002-8. doi: 10.4088/JCP.11m07493. J Clin Psychiatry. 2012. PMID: 22901350 Clinical Trial.

10

Generalized anxiety disorder: raising the expectations of treatment.

Allgulander C, Sheehan DV. Allgulander C, et al. Psychopharmacol Bull. 2002 Summer;36 Suppl 2:68-78. Psychopharmacol Bull. 2002. PMID: 17450651 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page